Notably, as we suggested that DAT binding contributed to disease severity in PSP, the different disease severity but similar DAT binding between the PSP-RS and PSP-non-RS groups to some extent seemed not rational. This evidence concerns the gene SLC6A3 and supranuclear palsy, progressive, 1.